UbiVac Employee Directory

Biotechnology ResearchOregon, United States2-10 Employees

UbiVac is a biotechnology research company based in Portland, Oregon, focused on research, development, and manufacture of therapeutic immune activators, vaccines, and cellular immunotherapies aimed at cancer treatment. Its work centers on combining these therapies with other immunotherapies, leveraging patented technologies to enhance anti-tumor responses and potentially improve survival in difficult-to-treat cancers, with preclinical and early clinical data cited in the provided information. The company engages in partnerships and collaborations to advance its lead product, DPV-001, including a first-in-human trial in collaboration with Providence Cancer Institute and Incyte for advanced head and neck squamous cell carcinoma, and it maintains a broader pipeline of cellular therapies. UbiVac positions itself within the biotechnology research sector as a translational and translational-immunotherapy-focused enterprise, drawing on senior leadership with extensive experience in preclinical and clinical adoptive immunotherapy. The organization has pursued external collaborations and clinical development efforts since its early activity, and recent public updates reflect ongoing development of its DPV-001 program and related immunotherapy initiatives.

Sign up for free to view info

Company overview Email format